When antidepressants don't work

Cowen, Philip
February 2004
Pulse;2/9/2004, Vol. 64 Issue 6, p45
Explains the reasons on the ineffectiveness of antidepressants and how to solve the problem. Administration of the appropriate dosage; Recognition of dose-response curves; Decision of switching to an alternative drug; Consideration of using monoamine oxidase inhibitors; Augmentation strategies.


Related Articles

  • Lithium augmentation therapy in tricyclic-resistant depression. A controlled trial using lithium in low and normal doses. Stein, George; Bernadt, Morris; Stein, G; Bernadt, M // British Journal of Psychiatry;May93, Vol. 162, p634 

    Thirty-four patients with tricyclic-resistant depressive illness took part in a nine-week, double-blind, placebo-controlled trial of lithium augmentation. In addition to the maximum tolerated doses of their tricyclic antidepressant, the experimental group (n = 16) received 250 mg lithium daily...

  • The antidepressant debate. Moncrieff, Joanna // British Journal of Psychiatry;Mar2002, Vol. 180, p193 

    The author reflects on the debate in the medical literature concerning the efficacy of antidepressant drugs. She discloses that several studies and researches had proven already that the intake of antidepressants promote various adverse effect. She particularly regards its impact to depressive...

  • Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Hayford, K. E.; Patten, C. A.; Rummans, T. A.; Schroeder, D. R.; Offord, K. P.; Croghan, L T.; Glover, E. D.; Sachs, D. P. L.; Hurt, R. D.; Croghan, I T; Sachs, D P // British Journal of Psychiatry;Feb99, Vol. 174, p173 

    Background: A past history of major depression or alcoholism has been associated with poorer smoking treatment outcomes.Aim: To evaluate the efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism, and changes in...

  • England's Antidepressant Ban.  // Antidepressants & Suicide: When Treatment Kills;2007, p55 

    The article reports that the British Medicines and Healthcare Products Regulatory Agency of Great Britain has banned Paxil for treatment of pediatric depression in June 2003. This regulation has followed the review of the available data for Paxil, an antidepressant medication. In December 2003,...

  • Treating depressive episode. Kristine Steffen; Roerig, James; Carls, Katie A. // Drug Topics;6/19/2006, Vol. 150 Issue 12, pHSE3 

    The article presents the case of a 28-year-old acutely suicidal pregnant woman who was diagnosed with a bipolar II disorder. She was noncompliant to her treatment which was composed of lithium and lamotrigine. The author suggests that electroconvulsive therapy is an attractive option because it...

  • Venlafaxine and paroxetine in treatment-resistant depression. Poirier, M.-F.; Boyer, P. // British Journal of Psychiatry;Jul99, Vol. 175, p12 

    Background About one-third of patients fail to respond to initial antidepressant therapy, which suggests a need for more effective drugs. Aims To compare the efficacy and safety of venlafaxine and paroxetine in 122 patients with non-chronic treatment-resistant depression. Method In-patients or...

  • Biochemical aspects of therapy-resistant depression. Leonard, B. E. // British Journal of Psychiatry;Apr88, Vol. 152, p453 

    Despite the relatively high incidence of therapy-resistant depression, there is little clinical evidence to suggest that there are significant biochemical differences between therapy-resistant and therapy-responsive patients. A major problem for investigators is the lack of an internationally...

  • Pindolol augmentation of antidepressant therapy. McAskill, R.; Mir, S.; Taylor, D. // British Journal of Psychiatry;Sep98, Vol. 173, p203 

    Background: Antidepressant therapy is not always effective and is slow to take effect. In theory, these shortfalls may be caused by induction of neuronal negative feedback via pre-synaptic 5-HTIA receptors. Pindolol, an antagonist at somatodentritic pre-synaptic 5-HTIA receptors has...

  • Controlled efficacy study of fluoxetine in dysthymia. Vanelle, Jean-Marie; Attar-Levy, Dominique; Poirier, Marie-France; Bouhassira, Myriam; Blin, Patrick; OliĆ©, Jean-Pierre // British Journal of Psychiatry;Apr97, Vol. 170, p245 

    Background There have been very few controlled studies of antidepressants in dysthymia, particularly in samples diagnosed reliably and with an adequate length of follow-up. In this investigation, we measured the long-term outcome in a large group of patients meeting DSM-III-R criteria for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics